{'fraction_non_alphanumeric': 0.022058823529411766, 'fraction_numerical': 0.0029411764705882353, 'mean_word_length': 5.300925925925926, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Practice evidence to put evidence into practice

In the Allergy issue of March 2004 the article Allergic Rhinitis and its Impact on Asthma (ARIA) in the Pharmacy has been published. This consensus document extends the concepts and recommendations included in the original WHO guidelines on ARIA to pharmacists. The fight against allergic diseases calls for a collaboration of all health professionals. Therefore, we consider the involvement of pharmacists in a balanced management of diseases with high prevalence, chronicity and significant socio-economic impact of extreme relevance and novelty. The ARIA in the Pharmacy guidelines as well as the original ARIA document and other guidelines stress the concept of practice being based on evidence. Evidence-based medicine (EBM) has introduced a series of new terms and concepts [such as meta-analysis, systematic reviews (SRs), grading of evidence and recommendations, randomized clinical trials – RCTs, etc.] whose relevance is widely accepted. However, not all research workers and practicing doctors are fully familiar with the complex background of these terms and concepts. This editorial aims at addressing some aspects of evidence that should be considered when writing or applying guidelines. It also provides a series of references to practice evidence, in order to better put evidence into practice.